Stocks
Neurocrine Biosciences (NBIX) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 56.4 | -2.75 | -1.45 | 20.5 | 19.6 | 17.0 | ||
| Changes by years, y/y, % | -2% | -105% | -47% | -1 511% | -4% | -19.4% | |||
Neurocrine Biosciences. EV/EBITDA
Neurocrine Biosciences. EV/EBITDA, changes, %
Neurocrine Biosciences (NBIX) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 19.5 | 17.8 | 13.8 | 18.1 | 18.6 | 17.0 | |
| Changes by years, y/y, % | +21% | -13% | -27% | -13% | -11% | |||
| Changes by quarters, q/q, % | -6% | -9% | -23% | +31% | +2% | |||
